Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.695 USD | +2.53% | +2.74% | +2.42% |
05-09 | Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-26 | Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.42% | 460M | |
+9.89% | 115B | |
+11.90% | 106B | |
-2.59% | 21.96B | |
-12.49% | 21.87B | |
-5.29% | 19.21B | |
-4.11% | 18.08B | |
-38.57% | 17.71B | |
+7.24% | 14.32B | |
+35.21% | 12.42B |
- Stock Market
- Equities
- NKTX Stock
- News Nkarta, Inc.
- Nkarta Therapeutics Promotes Nadir Mahmood to Chief Business Officer